CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes Effect of Plaque Burden and Morphology on Myocardial Blood Flow and Fractional Flow Reserve Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 Substudy Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association

Review Article2022;8:24-31 | 10.4244/AIJ-D-22-00005

JOURNAL:AsiaIntervention Article Link

Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?

Z-V Lee.

Full Text PDF